Jan Paul Ottervanger

9.4k total citations · 1 hit paper
236 papers, 6.4k citations indexed

About

Jan Paul Ottervanger is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Jan Paul Ottervanger has authored 236 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Cardiology and Cardiovascular Medicine, 107 papers in Radiology, Nuclear Medicine and Imaging and 96 papers in Surgery. Recurrent topics in Jan Paul Ottervanger's work include Acute Myocardial Infarction Research (125 papers), Cardiac Imaging and Diagnostics (106 papers) and Coronary Interventions and Diagnostics (81 papers). Jan Paul Ottervanger is often cited by papers focused on Acute Myocardial Infarction Research (125 papers), Cardiac Imaging and Diagnostics (106 papers) and Coronary Interventions and Diagnostics (81 papers). Jan Paul Ottervanger collaborates with scholars based in Netherlands, Germany and United States. Jan Paul Ottervanger's co-authors include Harry Suryapranata, Giuseppe De Luca, Arnoud W.J. van ‘t Hof, Elliott M. Antman, Jan C.A. Hoorntje, Felix Zijlstra, Menko‐Jan de Boer, Jan‐Henk E. Dambrink, A.T. Marcel Gosselink and Jorik R. Timmer and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Jan Paul Ottervanger

230 papers receiving 6.1k citations

Hit Papers

Time Delay to Treatment and Mortality in Primary Angiopla... 2004 2026 2011 2018 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction
    2004 1.1k citations Giuseppe De Luca, Harry Suryapranata et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Paul Ottervanger Netherlands 37 4.9k 2.2k 2.0k 748 490 236 6.4k
Menko‐Jan de Boer Netherlands 36 5.0k 1.0× 2.9k 1.3× 2.5k 1.3× 603 0.8× 438 0.9× 138 6.0k
Elmir Ömerovic Sweden 39 4.7k 1.0× 2.4k 1.1× 2.4k 1.2× 621 0.8× 299 0.6× 253 6.2k
Masaharu Ishihara Japan 37 3.7k 0.8× 2.0k 0.9× 1.8k 0.9× 715 1.0× 675 1.4× 264 5.5k
Lars Romer Krusell Denmark 33 3.3k 0.7× 2.2k 1.0× 1.6k 0.8× 750 1.0× 317 0.6× 92 4.9k
Michael C. Kontos United States 41 8.5k 1.7× 2.6k 1.2× 3.5k 1.7× 1.1k 1.5× 267 0.5× 185 10.7k
Rosemary F. Kelly United States 29 5.0k 1.0× 2.8k 1.3× 1.7k 0.8× 456 0.6× 192 0.4× 131 7.3k
Francis M. Fesmire United States 32 5.4k 1.1× 2.1k 1.0× 1.8k 0.9× 592 0.8× 261 0.5× 71 7.1k
Hanoch Hod Israel 39 5.2k 1.1× 2.0k 0.9× 1.5k 0.7× 297 0.4× 291 0.6× 155 6.0k
Omar Dabbous United States 33 3.8k 0.8× 1.7k 0.8× 1.3k 0.7× 318 0.4× 221 0.5× 119 6.0k
E. Magnus Ohman United States 38 4.7k 1.0× 2.8k 1.3× 1.2k 0.6× 450 0.6× 515 1.1× 93 7.2k

Countries citing papers authored by Jan Paul Ottervanger

Since Specialization
Citations

This map shows the geographic impact of Jan Paul Ottervanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Paul Ottervanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Paul Ottervanger more than expected).

Fields of papers citing papers by Jan Paul Ottervanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Paul Ottervanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Paul Ottervanger. The network helps show where Jan Paul Ottervanger may publish in the future.

Co-authorship network of co-authors of Jan Paul Ottervanger

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Paul Ottervanger. A scholar is included among the top collaborators of Jan Paul Ottervanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Paul Ottervanger. Jan Paul Ottervanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermanides, Rik, Jan-Henk Dambrink, M. Gosselink, et al.. (2024). Preoperative intra-aortic balloon pump in patients with ST-elevation myocardial infarction undergoing urgent cardiac bypass surgery. Netherlands Heart Journal. 32(7-8). 276–282.
2.
Dijk, J.D. van, Jorik R. Timmer, Jan Paul Ottervanger, et al.. (2023). The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT. Journal of Nuclear Cardiology. 30(6). 2692–2701. 1 indexed citations
3.
Ottervanger, Jan Paul, et al.. (2022). Mortality Reduction After a Preincision Safety Check Before Cardiac Surgery: Is It the Aorta?. Journal of Cardiothoracic and Vascular Anesthesia. 36(8). 2954–2960. 1 indexed citations
4.
Ottervanger, Jan Paul, et al.. (2022). Early home discharge after robot-assisted coronary artery bypass grafting. Interactive Cardiovascular and Thoracic Surgery. 35(1). 6 indexed citations
5.
Tolsma, Rudolf T, Marion Fokkert, Erik Badings, et al.. (2021). Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study. European Heart Journal Acute Cardiovascular Care. 11(2). 160–169. 26 indexed citations
6.
Karami, Mina, Krischan D. Sjauw, Annemarie E. Engström, et al.. (2020). Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock. PLoS ONE. 15(7). e0235762–e0235762. 13 indexed citations
7.
Ottervanger, Jan Paul, Rudolf T Tolsma, Marion Fokkert, et al.. (2019). In-Hospital Healthcare Utilization, Outcomes, and Costs in Pre-Hospital-Adjudicated Low-Risk Chest-Pain Patients. Applied Health Economics and Health Policy. 17(6). 875–882. 13 indexed citations
8.
Dijk, J.D. van, P.L. Jager, Jan Paul Ottervanger, Cornelis H. Slump, & J.A. van Dalen. (2019). No need for frame-wise attenuation correction in dynamic Rubidium-82 PET for myocardial blood flow quantification. Journal of Nuclear Cardiology. 26(3). 738–745. 6 indexed citations
9.
Fokkert, Marion, Rudolf T Tolsma, Erik Badings, et al.. (2018). Value of Prehospital Troponin Assessment in Suspected Non-ST-Elevation Acute Coronary Syndrome. The American Journal of Cardiology. 122(10). 1610–1616. 27 indexed citations
10.
Ottervanger, Jan Paul, Arnoud W.J. van ‘t Hof, J. H. E. Dambrink, et al.. (2016). Cardiogenic Shock Predicts Long‐term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention. Clinical Cardiology. 39(11). 665–669. 13 indexed citations
11.
Dijk, J.D. van, Piet L. Jager, Jan Paul Ottervanger, et al.. (2015). A practical approach for a patient-tailored dose protocol in coronary CT angiography using prospective ECG triggering. International journal of cardiac imaging. 32(3). 531–538. 1 indexed citations
12.
Ottervanger, Jan Paul, Jan‐Henk E. Dambrink, Jan C.A. Hoorntje, et al.. (2013). The effect of thrombus aspiration during primary percutaneous coronary intervention on clinical outcome in daily clinical practice. Thrombosis and Haemostasis. 111(1). 165–171. 16 indexed citations
13.
Hermanides, Renicus S., Jan Paul Ottervanger, Jurriën M. ten Berg, et al.. (2012). Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.. PubMed. 24(3). 84–9. 6 indexed citations
14.
Mouden, Mohamed, et al.. (2012). Prevalence and predictors of bridging of coronary arteries in a large Indonesian population, as detected by 64-slice computed tomography scan. Netherlands Heart Journal. 20(10). 396–401. 10 indexed citations
15.
Hermanides, Renicus S., Antonius A.C.M. Heestermans, Jurriën M. ten Berg, et al.. (2010). High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. Heart. 97(2). 106–111. 8 indexed citations
16.
Nienhuis, Mark B., Jan Paul Ottervanger, Henk J.G. Bilo, Bert D. Dikkeschei, & Felix Zijlstra. (2008). Prognostic value of troponin after elective percutaneous coronary intervention: A meta‐analysis. Catheterization and Cardiovascular Interventions. 71(3). 318–324. 134 indexed citations
17.
Nienhuis, Mark B., Jan Paul Ottervanger, Jan‐Henk E. Dambrink, et al.. (2008). Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction. Coronary Artery Disease. 20(1). 9–14. 24 indexed citations
18.
Ottervanger, Jan Paul, et al.. (2007). Are patients with non-ST elevation myocardial infarction undertreated?. SHILAP Revista de lepidopterología. 8 indexed citations
19.
Rasoul, Saman, Jan Paul Ottervanger, Jan‐Henk E. Dambrink, et al.. (2007). External validity of ST elevation myocardial infarction trials: The Zwolle studies. Catheterization and Cardiovascular Interventions. 69(5). 632–636. 7 indexed citations
20.
Luca, Giuseppe De, Harry Suryapranata, Arnoud W.J. van ‘t Hof, et al.. (2006). Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. American Heart Journal. 151(6). 1296.e1–1296.e6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Menko‐Jan de Boer Breakdown of academic impact, for papers by Elmir Ömerovic Breakdown of academic impact, for papers by Masaharu Ishihara Breakdown of academic impact, for papers by Lars Romer Krusell Breakdown of academic impact, for papers by Michael C. Kontos Breakdown of academic impact, for papers by Rosemary F. Kelly Breakdown of academic impact, for papers by Francis M. Fesmire Breakdown of academic impact, for papers by Hanoch Hod Breakdown of academic impact, for papers by Omar Dabbous Breakdown of academic impact, for papers by E. Magnus Ohman
Rankless by CCL
2026